Abstract:BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can differentiate into hepatocyte-like cells in vivo and vitro and show hepatocyte function such as synthesis and secretion. OBJECTIVE: To induce and differentiate BMSCs into hepatic cells, which are transplanted into homogeneitic rat livers that had fibrous degenerated, and to observe the distribution, differentiation and effects of the hepatocytes on hepatic function. DESIGN, TIME AND SETTING: Randomized controlled animal experiment was performed at the Laboratory of Hospital Affiliated to Luzhou Medical College from June 2007 to March 2008. MATERIALS: A total of 10 clean male Sprague Dawley rats weighing 100 g were selected to culture BMSCs and to be induced and differentiated into hepatocyte-like cells. A total of 75 clean male Sprague Dawley rats weighing 200-250 g were randomly divided into hepatocyte-like cell transplantation group (n=30), model control group (n=30) and normal control group (n=15). Rats in the hepatocyte-like cell transplantation group and model control group intraperitonealy underwent carbon tetrachloride to prepare animal models of hepatic fibrosis. METHODS: Rats in the model control group and normal control group were subjected to serum-free low-glucose DMEM via portal vein infusion. Rats in the hepatocyte-like cell transplantation group received DAPI labelled hepatocyte-like cells. All rats were sacrificed to obtain liver and serum samples at 1, 2, 3 and 4 weeks following transplantation. MAIN OUTCOME MEASURES: Degree of the hepatic fibrosis was evaluated though Masson triple stain. Frozen sections were made to detect transformation of livers which had been transplanted cells with a fluorescence microscope. Serum the parameters of liver function and hepatic fibrosis were detected by the automatic biochemistry analyzer and radio-immunifaction method. RESULTS: Transplanted cells from the blood vessels gradually accessed into the liver, and eventually distributed between the liver cells scattered. But after three weeks of transplantation, fluorescence obviously decayed. At week 2, liver false lobular gradually absorbed or dissipated, and fibrosis significantly milder than the model control group, with collagen staining lighting and distributing in the fiber interval and portal area, and liver cells presented Balloon-like degeneration. At week 4, liver cells arranged in normal. Dot necrosis was occasionally found without fiber interval. No significant differences in the parameters of liver function and hepatic fibrosis were found compared with the normal control group(P > 0.05). CONCLUSION: Induced hepatocyte-like cells could engraft into fibrotic liver after transfusion as early as on the 7th day and localized in collection tube region and liver sinus. Results of biochemistry detection showed that the engrafted hepatocyte-like cells could substitute liver function partly.

Orthotopic Transplantation of Functional Bioengineered Livers in Rats.

Establishment of a New Pig Model for Auxiliary Partial Orthotopic Liver Transplantation

Advances in cell sources of hepatocytes for bioartificial liver.

Experimental study of bioartificial liver with cultured human liver cells.

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

Heterotopic Vascularization and Functionalization of Implantable Bio Engineered Hepatic Tissue Alleviates Liver Injury in Rats

Construction of a Portal Implantable Functional Tissue-Engineered Liver Using Perfusion-Decellularized Matrix and Hepatocytes in Rats

Liver organoids cocultured on decellularized native liver scaffolds as a bridging therapy improves survival from liver failure in rabbits

Feasibility of Orthotopic Fetal Liver Transplantation: an Experimental Study.

Allogeneic Liver Transplantation and Subsequent Syngeneic Hepatocyte Transplantation in a Rat Model: Proof of Concept for in vivo Tissue Engineering

A Novel Model for Orthotopic Liver Transplantation in Rats Using Hepatic Rearterialization and Biliary Extradrainage System

Development of highly functional bioengineered human liver with perfusable vasculature

Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes

In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats.

A bioartificial liver support system integrated with a DLM/GelMA-based bioengineered whole liver for prevention of hepatic encephalopathy via enhanced ammonia reduction.

Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice.

Ectopic expansion and vascularization of engineered hepatic tissue based on heparinized acellular liver matrix and mesenchymal stromal cell spheroids

Cross-circulation combined with rapidly deployable veno-venous bypass grafts for multi-organ biosystemic support in liver failure: Experimental studies.

Functionalized Vascular Structure in Bioengineered Liver Identified with Proteomics